Ana Martı́nez

18.4k total citations
461 papers, 12.3k citations indexed

About

Ana Martı́nez is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ana Martı́nez has authored 461 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 185 papers in Molecular Biology, 143 papers in Organic Chemistry and 85 papers in Pharmacology. Recurrent topics in Ana Martı́nez's work include Cholinesterase and Neurodegenerative Diseases (76 papers), Phosphodiesterase function and regulation (42 papers) and Computational Drug Discovery Methods (40 papers). Ana Martı́nez is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (76 papers), Phosphodiesterase function and regulation (42 papers) and Computational Drug Discovery Methods (40 papers). Ana Martı́nez collaborates with scholars based in Spain, United States and Germany. Ana Martı́nez's co-authors include Ana Castro, Carmen Gil, Daniel I. Pérez, Concepción Pérez, Mercedes Alonso, Valle Palomo, Isabel Dorronsoro, Hagit Eldar-Finkelman, Ana Pérez‐Castillo and Nuria E. Campillo and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ana Martı́nez

438 papers receiving 12.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ana Martı́nez 5.3k 3.1k 3.0k 1.7k 1.7k 461 12.3k
Stefan Laufer 6.8k 1.3× 2.2k 0.7× 4.0k 1.3× 1.5k 0.9× 1.2k 0.7× 469 15.2k
Alan P. Kozikowski 12.4k 2.3× 2.8k 0.9× 9.1k 3.1× 1.1k 0.6× 1.1k 0.7× 567 23.3k
Craig J. Thomas 7.0k 1.3× 2.2k 0.7× 1.7k 0.6× 828 0.5× 686 0.4× 250 15.2k
H. Eric Xu 14.5k 2.7× 1.5k 0.5× 1.3k 0.4× 3.3k 1.9× 1.1k 0.7× 326 24.1k
Peter M. Blumberg 15.9k 3.0× 2.4k 0.8× 2.0k 0.7× 4.5k 2.6× 753 0.5× 451 26.1k
Masahiko Negishi 15.7k 2.9× 4.4k 1.4× 1.1k 0.4× 2.8k 1.6× 707 0.4× 514 33.2k
Brian R. Smith 4.3k 0.8× 994 0.3× 2.6k 0.9× 381 0.2× 2.2k 1.3× 125 10.5k
Christopher Southan 7.1k 1.3× 1.7k 0.6× 327 0.1× 2.9k 1.7× 1.2k 0.7× 120 15.5k
Mati Fridkin 6.2k 1.2× 1.1k 0.4× 1.1k 0.4× 1.6k 0.9× 369 0.2× 355 13.4k
Yoshiaki Kiso 5.4k 1.0× 669 0.2× 3.0k 1.0× 1.1k 0.6× 1.3k 0.8× 402 11.7k

Countries citing papers authored by Ana Martı́nez

Since Specialization
Citations

This map shows the geographic impact of Ana Martı́nez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Martı́nez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Martı́nez more than expected).

Fields of papers citing papers by Ana Martı́nez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Martı́nez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Martı́nez. The network helps show where Ana Martı́nez may publish in the future.

Co-authorship network of co-authors of Ana Martı́nez

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Martı́nez. A scholar is included among the top collaborators of Ana Martı́nez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Martı́nez. Ana Martı́nez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuevas, Eva P., Enrique López Madruga, David Ramírez, et al.. (2025). MicroRNA signature of lymphoblasts from amyotrophic lateral sclerosis patients as potential clinical biomarkers. Neurobiology of Disease. 208. 106871–106871. 2 indexed citations
2.
3.
Godoy, Pere, Núria Soldevila, Ana Martı́nez, et al.. (2024). Effectiveness of Influenza Vaccination and Early Antiviral Treatment in Reducing Pneumonia Risk in Severe Influenza Cases. Vaccines. 12(2). 173–173. 3 indexed citations
4.
Domı́nguez, Ángela, Ana Avellón, Víctoria Hernando, et al.. (2024). Hepatitis B Virus-Related Cirrhosis and Hepatocellular Carcinoma Hospital Discharge Rates from 2005 to 2021 in Spain: Impact of Universal Vaccination. Vaccines. 12(11). 1254–1254. 2 indexed citations
5.
Carneros, Elena, Ralf Welsch, Klaus Palme, et al.. (2024). Small molecule inhibitors of human LRRK2 enhance in vitro embryogenesis and microcallus formation for plant regeneration of crop and model species. Journal of Plant Physiology. 303. 154334–154334. 1 indexed citations
6.
Domı́nguez, Ángela, Ana Avellón, Víctoria Hernando, et al.. (2024). Impact of the Universal Implementation of Adolescent Hepatitis B Vaccination in Spain. Vaccines. 12(5). 488–488. 1 indexed citations
7.
Martínez‐González, Loreto, Eva P. Cuevas, Vanesa Nozal, et al.. (2023). TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer’s disease patients. Frontiers in Molecular Neuroscience. 16. 1243277–1243277. 9 indexed citations
8.
Maestro, Inés, Enrique López Madruga, Patricia Boya, & Ana Martı́nez. (2023). Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2153841–2153841. 9 indexed citations
9.
Reggiori, Fulvio, Patricia Boya, David Da Costa, et al.. (2022). The mechanism of macroautophagy: The movie. SHILAP Revista de lepidopterología. 1(1). 414–417. 1 indexed citations
10.
Wells, Geoffrey, Ángeles Martín‐Requero, Ana Martı́nez, et al.. (2022). Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis. Journal of Medicinal Chemistry. 65(3). 1867–1882. 17 indexed citations
11.
Nozal, Vanesa, Loreto Martínez‐González, Paula Santana, et al.. (2022). TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy. Journal of Medicinal Chemistry. 65(2). 1585–1607. 28 indexed citations
12.
Lastres‐Becker, Isabel, Marina Arribas-Blázquez, Inés Maestro, et al.. (2021). Molecular Alterations in Sporadic and SOD1-ALS Immortalized Lymphocytes: Towards a Personalized Therapy. International Journal of Molecular Sciences. 22(6). 3007–3007. 22 indexed citations
13.
Varela, Carmen, Núria Soldevila, Conchita Izquierdo, et al.. (2021). Hepatitis A Outbreak Characteristics: A Comparison of Regions with Different Vaccination Strategies, Spain 2010–2018. Vaccines. 9(11). 1214–1214. 1 indexed citations
14.
Koçak, Muhammed, Inés Maestro, Judith Farrés, et al.. (2021). Targeting autophagy in disease: established and new strategies. Autophagy. 18(3). 473–495. 139 indexed citations
15.
Maestro, Inés, Patricia Boya, & Ana Martı́nez. (2020). Serum- and glucocorticoid-induced kinase 1, a new therapeutic target for autophagy modulation in chronic diseases. Expert Opinion on Therapeutic Targets. 24(3). 231–243. 15 indexed citations
16.
Roca, Carlos, Concepción Pérez, Ana Martı́nez, et al.. (2019). From simple quinoxalines to potent oxazolo[5,4-f]quinoxaline inhibitors of glycogen-synthase kinase 3 (GSK3). Organic & Biomolecular Chemistry. 18(1). 154–162. 11 indexed citations
17.
Forero‐Doria, Oscar, et al.. (2019). Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases. Processes. 7(12). 940–940. 7 indexed citations
18.
Li, Lingling, Ana M. García, Wen‐Ning Zhao, et al.. (2019). Benzothiazole-Based LRRK2 Inhibitors as Wnt Enhancers and Promoters of Oligodendrocytic Fate. Journal of Medicinal Chemistry. 63(5). 2638–2655. 17 indexed citations
19.
Kraft, Claudine, Patricia Boya, Patrice Codogno, et al.. (2018). Driving next-generation autophagy researchers towards translation (DRIVE), an international PhD training program on autophagy. Autophagy. 15(2). 347–351. 4 indexed citations
20.
Andrade, Peterson de, Carlos Roca, Concepción Pérez, et al.. (2018). Highly potent and selective aryl-1,2,3-triazolyl benzylpiperidine inhibitors toward butyrylcholinesterase in Alzheimer's disease. Bioorganic & Medicinal Chemistry. 27(6). 931–943. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan Laufer Breakdown of academic impact, for papers by Alan P. Kozikowski Breakdown of academic impact, for papers by Craig J. Thomas Breakdown of academic impact, for papers by H. Eric Xu Breakdown of academic impact, for papers by Peter M. Blumberg Breakdown of academic impact, for papers by Masahiko Negishi Breakdown of academic impact, for papers by Brian R. Smith Breakdown of academic impact, for papers by Christopher Southan Breakdown of academic impact, for papers by Mati Fridkin Breakdown of academic impact, for papers by Yoshiaki Kiso
Rankless by CCL
2026